Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases - Trial NCT06411015
Access comprehensive clinical trial information for NCT06411015 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud University Medical Center and is currently Completed. The study focuses on Predictive Cancer Model. Target enrollment is 428 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Radboud University Medical Center
Timeline & Enrollment
N/A
Jan 01, 2021
May 01, 2024
Primary Outcome
survival after diagnosis of spinal metastasis
Summary
Patients with symptomatic spinal metatstasis will be prosepectively included in a database
 after theu signes informed consent. Minimally six months after inclusion the survival status
 is analyzed. These are correlated with factors that are used in an earlier develloped
 prediction model
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411015
Non-Device Trial